Arcus Biosciences prices $250 million stock offering at $17.50
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
China, Russia Signal Resilient Ties Amid US Moves
Bloomberg's Minmin Low says Beijing and Moscow are doubling down on strategic and energy ties following Vladimir Putin’s meetings with US envoy Steve Witkoff, signaling close bilateral coordination…
Las Vegas Sands: 3 Key Takeaways for Long-Term Investors
Service investments in Macao are driving market share gains despite near-term softness among luxury customers, a sign of operational resilience.
Young Poong loses shareholder derivative suit against Korea Zinc
A court on Thursday ruled against Young Poong Corp. in a shareholder derivative lawsuit seeking 837 billion won ($631 million) in damages from Korea Zinc Co.